• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情与阿尔茨海默病:共同的风险和机制。

The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.

机构信息

Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences & Yunnan Province Kunming Institute of Zoology Chinese Academy of Sciences, Kunming, Yunnan, China.

出版信息

Transl Neurodegener. 2022 Sep 11;11(1):40. doi: 10.1186/s40035-022-00316-y.

DOI:10.1186/s40035-022-00316-y
PMID:36089575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9464468/
Abstract

Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a life-threatening disease, especially in elderly individuals and those with comorbidities. The predominant clinical manifestation of COVID-19 is respiratory dysfunction, while neurological presentations are increasingly being recognized. SARS-CoV-2 invades host cells primarily via attachment of the spike protein to the angiotensin-converting enzyme 2 (ACE2) receptor expressed on cell membranes. Patients with Alzheimer's disease (AD) are more susceptible to SARS-CoV-2 infection and prone to severe clinical outcomes. Recent studies have revealed some common risk factors for AD and COVID-19. An understanding of the association between COVID-19 and AD and the potential related mechanisms may lead to the development of novel approaches to treating both diseases. In the present review, we first summarize the mechanisms by which SARS-CoV-2 invades the central nervous system (CNS) and then discuss the associations and potential shared key factors between COVID-19 and AD, with a focus on the ACE2 receptor, apolipoprotein E (APOE) genotype, age, and neuroinflammation.

摘要

新型冠状病毒病(COVID-19)由严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)引起,是一种危及生命的疾病,尤其对老年人和有合并症的患者而言。COVID-19 的主要临床表现为呼吸系统功能障碍,而神经系统表现也越来越受到重视。SARS-CoV-2 主要通过其刺突蛋白与细胞膜上表达的血管紧张素转换酶 2(ACE2)受体结合来入侵宿主细胞。阿尔茨海默病(AD)患者更容易感染 SARS-CoV-2,且易出现严重的临床结局。最近的研究揭示了 AD 和 COVID-19 的一些共同危险因素。了解 COVID-19 和 AD 之间的关联及其潜在的相关机制,可能会为治疗这两种疾病提供新的方法。在本综述中,我们首先总结了 SARS-CoV-2 入侵中枢神经系统(CNS)的机制,然后讨论了 COVID-19 和 AD 之间的关联和潜在的共同关键因素,重点关注 ACE2 受体、载脂蛋白 E(APOE)基因型、年龄和神经炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/9465929/4650acad7e4b/40035_2022_316_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/9465929/df9ec02056a6/40035_2022_316_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/9465929/70ae11b128d8/40035_2022_316_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/9465929/8daa01b587f2/40035_2022_316_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/9465929/4650acad7e4b/40035_2022_316_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/9465929/df9ec02056a6/40035_2022_316_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/9465929/70ae11b128d8/40035_2022_316_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/9465929/8daa01b587f2/40035_2022_316_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/9465929/4650acad7e4b/40035_2022_316_Fig4_HTML.jpg

相似文献

1
The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms.新冠疫情与阿尔茨海默病:共同的风险和机制。
Transl Neurodegener. 2022 Sep 11;11(1):40. doi: 10.1186/s40035-022-00316-y.
2
Links between COVID-19 and Alzheimer's Disease-What Do We Already Know?新冠病毒与阿尔茨海默病之间的联系——我们已经了解了哪些?
Int J Environ Res Public Health. 2023 Jan 25;20(3):2146. doi: 10.3390/ijerph20032146.
3
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
4
Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.阿尔茨海默病大脑边缘区域中普遍存在 SARS-CoV-2 受体 ACE2 及其上调。
Folia Neuropathol. 2021;59(3):232-238. doi: 10.5114/fn.2021.109495.
5
COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.COVID-19 和阿尔茨海默病具有共同的神经和眼科表现:后疫情时代的双向风险。
Cells. 2023 Nov 10;12(22):2601. doi: 10.3390/cells12222601.
6
ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway.载脂蛋白 E4 通过下调 ACE2 和失衡的 RAS 通路与严重的 COVID-19 结局相关。
J Transl Med. 2023 Feb 9;21(1):103. doi: 10.1186/s12967-023-03945-7.
7
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.血管紧张素转换酶 2 的器官保护作用及其对 COVID-19 预后的影响。
J Med Virol. 2020 Jul;92(7):726-730. doi: 10.1002/jmv.25785. Epub 2020 Apr 5.
8
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.SARS-CoV-2 大流行和研究空白:了解 SARS-CoV-2 与 ACE2 受体的相互作用及其对治疗的影响。
Theranostics. 2020 Jun 12;10(16):7448-7464. doi: 10.7150/thno.48076. eCollection 2020.
9
Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.SARS-CoV-2 与其他冠状病毒与 ACE(血管紧张素转换酶)-2 作为其主要受体的相互作用:治疗意义。
Hypertension. 2020 Nov;76(5):1339-1349. doi: 10.1161/HYPERTENSIONAHA.120.15256. Epub 2020 Aug 27.
10
Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.新型冠状病毒肺炎与脑卒中:临床特征与病理生理学见解。
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104941. doi: 10.1016/j.jstrokecerebrovasdis.2020.104941. Epub 2020 May 12.

引用本文的文献

1
Longitudinal plasma proteomic evidence linking SARS-CoV-2 infection to increased β-amyloid pathology.纵向血浆蛋白质组学证据表明,SARS-CoV-2感染与β-淀粉样蛋白病理学增加有关。
Sci China Life Sci. 2025 Aug 13. doi: 10.1007/s11427-025-3011-y.
2
Exposure to COVID-19 virus-like particles modulates firing patterns of cortical neurons in the mouse brain.暴露于新冠病毒样颗粒会调节小鼠大脑皮层神经元的放电模式。
Commun Biol. 2025 Jul 3;8(1):993. doi: 10.1038/s42003-025-08435-8.
3
Need for awareness and surveillance of long-term post-COVID neurodegenerative disorders. A position paper from the neuroCOVID-19 task force of the European Academy of Neurology.

本文引用的文献

1
Inflammasome activation in infected macrophages drives COVID-19 pathology.在被感染的巨噬细胞中激活炎症小体导致 COVID-19 病理学。
Nature. 2022 Jun;606(7914):585-593. doi: 10.1038/s41586-022-04802-1. Epub 2022 Apr 28.
2
Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in Italy.意大利一家三级记忆诊所的研究结果:社区居住的痴呆症患者中 COVID-19 疫苗接种的流行情况和安全性。
J Alzheimers Dis. 2022;87(4):1467-1474. doi: 10.3233/JAD-220077.
3
COVID-19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021.
对新冠后长期神经退行性疾病的认识和监测需求。欧洲神经病学学会神经新冠-19工作组的立场文件。
J Neurol. 2025 May 6;272(6):380. doi: 10.1007/s00415-025-13110-3.
4
The COVID-19 Pandemic and Dementia: a Multijurisdictional Meta-Analysis of the Impact of the First Two Pandemic Waves on Acute Health-care Utilization and Mortality in Canada.2019年冠状病毒病大流行与痴呆症:对加拿大前两波大流行对急性医疗保健利用和死亡率影响的多辖区荟萃分析
Can Geriatr J. 2025 Mar 1;28(1):16-30. doi: 10.5770/cgj.28.776. eCollection 2025 Mar.
5
Inhibition of IFITM3 in cerebrovascular endothelium alleviates Alzheimer's-related phenotypes.抑制脑血管内皮细胞中的IFITM3可减轻阿尔茨海默病相关表型。
Alzheimers Dement. 2025 Feb;21(2):e14543. doi: 10.1002/alz.14543. Epub 2025 Jan 14.
6
Medical visits and mortality among dementia patients during the COVID-19 pandemic compared to rates predicted from 2019.新冠大流行期间痴呆症患者的就诊次数和死亡率与 2019 年预测的比率相比。
BMC Geriatr. 2024 Sep 2;24(1):727. doi: 10.1186/s12877-024-05298-2.
7
SARS-CoV-2 amyloid, is COVID-19-exacerbated dementia an amyloid disorder in the making?严重急性呼吸综合征冠状病毒2型淀粉样蛋白,新冠病毒感染相关的痴呆症会演变成一种淀粉样蛋白疾病吗?
Front Dement. 2023 Jul 6;2:1233340. doi: 10.3389/frdem.2023.1233340. eCollection 2023.
8
Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer's Disease.减少新冠病毒在大脑中的淀粉样蛋白沉积并预防新冠病毒加剧的痴呆症和阿尔茨海默病的潜在策略。
Pharmaceuticals (Basel). 2024 Jun 16;17(6):788. doi: 10.3390/ph17060788.
9
Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement.探索长新冠的病理生理学:低度炎症和多系统受累的核心作用。
Int J Mol Sci. 2024 Jun 9;25(12):6389. doi: 10.3390/ijms25126389.
10
Prenatal SARS-CoV-2 infection results in neurodevelopmental and behavioral outcomes in mice.产前感染 SARS-CoV-2 会导致小鼠的神经发育和行为结果。
JCI Insight. 2024 May 23;9(13):e179068. doi: 10.1172/jci.insight.179068.
2020 年 12 月至 2021 年 8 月期间,美国接种疫苗的痴呆症患者中 COVID-19 突破性感染和住院情况。
Alzheimers Dement. 2023 Feb;19(2):421-432. doi: 10.1002/alz.12669. Epub 2022 Apr 13.
4
Clinical outcomes of COVID-19 infection among patients with Alzheimer's disease or mild cognitive impairment.COVID-19 感染在阿尔茨海默病或轻度认知障碍患者中的临床结局。
Alzheimers Dement. 2022 May;18(5):911-923. doi: 10.1002/alz.12665. Epub 2022 Apr 4.
5
Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.针对大脑肾素-血管紧张素系统预防和治疗阿尔茨海默病:过去、现在和未来。
Ageing Res Rev. 2022 May;77:101612. doi: 10.1016/j.arr.2022.101612. Epub 2022 Mar 26.
6
SARS-CoV-2 is associated with changes in brain structure in UK Biobank.在英国生物银行中,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与大脑结构变化有关。
Nature. 2022 Apr;604(7907):697-707. doi: 10.1038/s41586-022-04569-5. Epub 2022 Mar 7.
7
Alzheimer's-like signaling in brains of COVID-19 patients.COVID-19 患者大脑中的类阿尔茨海默病信号。
Alzheimers Dement. 2022 May;18(5):955-965. doi: 10.1002/alz.12558. Epub 2022 Feb 3.
8
Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.表达人血管紧张素转换酶 2 的仓鼠在接触 SARS-CoV-2 后会发展为严重疾病。
mBio. 2022 Feb 22;13(1):e0290621. doi: 10.1128/mbio.02906-21. Epub 2022 Jan 25.
9
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.COVID-19 患者的脑脊液检查结果:127 例患者 150 次腰椎穿刺的多中心研究。
J Neuroinflammation. 2022 Jan 20;19(1):19. doi: 10.1186/s12974-021-02339-0.
10
APOE4 derived from astrocytes leads to blood-brain barrier impairment.源自星形胶质细胞的载脂蛋白E4会导致血脑屏障受损。
Brain. 2022 Oct 21;145(10):3582-3593. doi: 10.1093/brain/awab478.